0000000001276017

AUTHOR

Carmen Ribes-koninckx

showing 6 related works from this author

Fast blue B functionalized silica-polymer composite to evaluate 3,5-dihy-droxyhydrocinnamic acid as biomarker of gluten intake

2021

Celiac disease is an immune-mediated systemic disorder elicited by gluten and related prolamines in genetically susceptible individuals. The current treatment is a strict and lifelong gluten-free diet. However, compliance with the gluten-free diet is not always adequate and many food products contain low concentrations of gluten. The determination of dietary transgressions is a challenge for patients, physicians and dietitians. Alkylresorcinols (AR) have been proposed as sensitive and specific biomarkers of gluten consumption. In this work silica-polymer composites doped with fast blue B reagent (FB) have been used to estimate alkylresorcinols in biological samples. The proposed colorimetri…

alkylresorcinols02 engineering and technology010402 general chemistry01 natural sciencesfast blue BMaterials ChemistryElectrical and Electronic EngineeringInstrumentationFast blueVolume concentrationchemistry.chemical_classificationChromatographyMetals and AlloysbiomarkersGluten intake021001 nanoscience & nanotechnologyCondensed Matter PhysicsGlutencapillary liquid chromatography0104 chemical sciencesSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialschemistryReagentFood productsPDMS compositesPolymer compositesBiomarker (medicine)0210 nano-technologyceliac disease
researchProduct

MOESM2 of Direct conversion of human fibroblast to hepatocytes using a single inducible polycistronic vector

2019

Additional file 2: Table S1. Primers used for qRT-PCR.

researchProduct

MOESM1 of Direct conversion of human fibroblast to hepatocytes using a single inducible polycistronic vector

2019

Additional file 1: Figure S1. Cell sorting strategy using BDFACSAriaIIIâ ˘ cell sorter. Figure S2. Validation of the polycistroniclentiviral vector in HDF.

3. Good health
researchProduct

Direct conversion of human fibroblast to hepatocytes using a single inducible polycistronic vector

2019

Abstract Background Human fibroblasts can be reprogrammed into induced hepatocyte-like cells through the expression of a set of transcription factors. Although the generation of induced hepatocyte-like cells by HNF4A, HNF1A, and FOXA3 expression has proven to be a robust experimental strategy, using multiple lentivirus results in a highly variable heterogeneous population. Methods We designed and implemented a novel approach based on the delivery of reprogramming factors and green fluorescent protein in a single doxycycline-inducible lentiviral vector using 2A self-cleaving peptides. Results Fibroblasts infected with the lentiviral vector can be amplified in basic fibroblast culture media i…

Male0301 basic medicineInducibleGenetic VectorsGreen Fluorescent ProteinsMedicine (miscellaneous)Biochemistry Genetics and Molecular Biology (miscellaneous)Cell LineViral vectorGreen fluorescent proteinlcsh:BiochemistryMice03 medical and health sciences0302 clinical medicinePolycistronic vectorsmedicineAnimalsHumanslcsh:QD415-436TransgenesFibroblastGeneTranscription factorlcsh:R5-920ChemistryResearchReprogrammingDermisCell BiologyFibroblastsCellular ReprogrammingCell biologyInduced hepatocyte-like cellsiHEPPhenotype030104 developmental biologymedicine.anatomical_structureGenes030220 oncology & carcinogenesisDoxycyclineHepatocytesMolecular MedicineFOXA3Stem celllcsh:Medicine (General)ReprogrammingStem Cell Research & Therapy
researchProduct

High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin

2010

Pegylated interferon (PEG-IFN) alfa-2b plus ribavirin (RBV) is the standard of care for adults with chronic hepatitis C but was not approved for the treatment of children at the time of this study. The aim of this study was to evaluate the efficacy and safety of PEG-IFN alfa-2b plus RBV in children.Children and adolescents ages 3-17 years were treated with PEG-IFN alfa-2b (60microg/m(2)/week) plus RBV (15mg/kg/day). The duration of therapy was 24 weeks for genotype (G) 2 and G3 patients with low viral load (600,000IU/ml) and 48 weeks for G1, G4, and G3 with high viral load (or=600,000IU/ml). The primary end point was sustained virologic response (SVR), defined as undetectable hepatitis C vi…

Malemedicine.medical_specialtyAdolescentGenotypeHepatitis C virusHepacivirusInterferon alpha-2medicine.disease_causeAntiviral AgentsPolyethylene Glycolschemistry.chemical_compoundChild DevelopmentPegylated interferonInternal medicineDrug Resistance ViralRibavirinmedicineHumansChildAdverse effectHepatologybusiness.industryRibavirinBody WeightInterferon-alphaHepatitis CHepatitis C ChronicViral Loadmedicine.diseaseBody HeightRecombinant ProteinsTreatment OutcomechemistryChild PreschoolImmunologyPeginterferon alfa-2bDrug Therapy CombinationFemaleViral hepatitisbusinessViral loadmedicine.drugJournal of Hepatology
researchProduct

MOESM1 of Direct conversion of human fibroblast to hepatocytes using a single inducible polycistronic vector

2019

Additional file 1: Figure S1. Cell sorting strategy using BDFACSAriaIIIâ ˘ cell sorter. Figure S2. Validation of the polycistroniclentiviral vector in HDF.

3. Good health
researchProduct